CoChat

Chronic and progressive Parkinson's disease MPTP model in adult and aged mice

Open access
Muñoz‐Manchado, Ana B., Villadiego, Javier, Romo‐Madero, Sonia, Suárez‐Luna, Nela, Bermejo‐Navas, Alfonso, Rodríguez‐Gómez, José A., Garrido‐Gil, Pablo, Labandeira‐García, José L., Echevarría, Miriam, López‐Barneo, José, Toledo‐Aral, Juan J. · 2016 · Journal of Neurochemistry
Cited by 92

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Despite the different animal models of Parkinson's disease developed during the last years, they still present limitations modelling the slow and progressive process of neurodegeneration. Here, we undertook a histological, neurochemical and behavioural analysis of a new chronic parkinsonian mouse model generated by the subcutaneous administration of low doses of MPTP (20 mg/kg, 3 times per week) for 3 months, using both young adult and aged mice. The MPTP‐induced nigrostriatal neurodegeneration was progressive and was accompanied by a decrease in striatal dopamine levels and motor impairment. We also demonstrated the characteristic neuroinflammatory changes (microglial activation and astrogliosis) associated with the neurodegenerative process. Aged animals showed both a faster time course of neurodegeneration and an altered neuroinflammatory response. The long‐term systemic application of low MPTP doses did not induce any increase in mortality in either young adult or aged mice and better resembles the slow evolution of the neurodegenerative process. This treatment could be useful to model different stages of Parkinson's disease, providing a better understanding of the pathophysiology of the disease and facilitating the testing of both protective and restorative treatments. image Here, we show a new chronic and progressive parkinsonian mouse model, in young and aged mice. This model produces a stable degeneration of the dopaminergic nigrostriatal pathway, continuous neuroinflammatory reaction and motor deficits. Aged animals showed a faster neurodegeneration and an altered neuroinflammatory response. This treatment could be useful to model different stages of PD and to test both protective and restorative therapeutic approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jnc.13409

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 92

Metadata

Authors
Muñoz‐Manchado, A. B., Villadiego, J., Romo‐Madero, S., Suárez‐Luna, N., Bermejo‐Navas, A., Rodríguez‐Gómez, J. A., Garrido‐Gil, P., Labandeira‐García, J. L., Echevarría, M., López‐Barneo, J., & Toledo‐Aral, J. J.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2015-11-24
Volume
136
Issue
2
Pages
373-387
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2163543612
Cited by
92
References
11
FWCI
4.45
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic and progressive Parkinson's disease MPTP model in adult and aged mice. https://app.cochat.ai/papers/10.1111/jnc.13409
The paper
Muñoz‐Manchado, A. B., Villadiego, J., Romo‐Madero, S., Suárez‐Luna, N., Bermejo‐Navas, A., Rodríguez‐Gómez, J. A., Garrido‐Gil, P., Labandeira‐García, J. L., Echevarría, M., López‐Barneo, J., & Toledo‐Aral, J. J. (2016). Chronic and progressive Parkinson's disease MPTP model in adult and aged mice. Journal of Neurochemistry. https://doi.org/10.1111/jnc.13409

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.